Mergers and Acquisitions

Samsung Biologics to Acquire Full Ownership of Samsung Bioepis in $2.3 Billion Deal

January 28, 2022

Samsung Biologics has signed an agreement with Biogen to acquire Biogen’s 50% stake in Samsung Bioepis, a joint venture formed by the two companies, for up to $2.3 billion.

PharmaLex furthers its clinical and regulatory reach

January 27, 2022

Merger with Phlexglobal expands provider’s technological capabilities.

PharmaLex Expands Integrated Market Access Expertise through Merger with MAP Group

January 21, 2022

PharmaLex Group has merged with MAP Group, broadening its market access expertise and extending its reach into the Italian marketplace.

Protagen Protein Services, BioAnalytix, and GeneWerk Combine to Form New CRO, ProtaGene

January 18, 2022

After a previously announced merger, Protagen Protein Services, BioAnalytix, and GeneWerk have formed a new CRO under the name ProtaGene.

Insightful Science Completes Acquisition of Protein Metrics

January 07, 2022

The acquisition of Protein Metrics expands Insightful Science’s R&D solutions to include proteomics.

BBI Solutions Acquires BioTeZ Berlin-Buch

January 07, 2022

BBI Solutions has completed the acquisition of BioTeZ Berlin-Buch—a Germany-based manufacturer of reagents and finished tests for the in-vitro diagnostics market.

Asahi Kasei Medical Acquires Bionique

December 17, 2021

Bionique Testing Laboratories has been acquired by Asahi Kasei Medical and will join the company’s biosafety testing services unit.

Sanofi to Acquire Origimm Biotechnology for Vaccine-based Acne Treatment

December 09, 2021

Sanofi’s acquisition of Origimm Biotechnology will add to its pipeline of vaccine candidates for treating acne.

Lonza Acquires Exosomics Service Unit and Codiak BioSciences Exosomes Manufacturing Facility

November 03, 2021

Lonza is expanding its exosomes development and manufacturing capabilities with the acquisition of a service unit from Exosomics and a manufacturing facility from Codiak BioSciences.

ten23 health Acquires swissfillon to Enhance its Integrated Offering

October 29, 2021

Global CDMO, ten23 health, has acquired filling technology and drug product manufacturing expert, swissfillon, enhancing its integrated offering.